News | November 05, 2024
Lonza’s Synaffix collaborates with BigHat Biosciences for ML-designed ADC
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
Aims to achieve CDMO sales of US$ 400 million by 2028
MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
Developed in consultation with clinicians and patients for an enhanced user experience
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
MoU signed to drive digital transformation through strategic projects across all three business sectors of Merck
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
Subscribe To Our Newsletter & Stay Updated
